Zhang, Tao
Liu, Yanting
Liu, Fang
Guo, Kaiyu
Tang, Runhua
Ye, Jingwei
Xue, Li
Su, Zhipeng
Wu, Zhe Bao
Funding for this research was provided by:
National Natural Science Foundation of China (82002627, 82172605, 82472640)
Key Research Project of Traditional Chinese Medicine of Zhejiang Province of China (GZY-ZJ-KJ-24087)
Basic scientific research project of Wenzhou City of China (Y2023150)
National Research Center for Translational Medicine (NRCTM (SH) 2019-05)
Article History
Received: 29 November 2024
Accepted: 25 January 2025
First Online: 5 February 2025
Declarations
:
: Samples of pituitary adenomas (PAs) were obtained from patients undergoing surgical procedures at Ruijin Hospital between 2016 and 2023. The study received ethical approval from the Ethical Review Board of Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine (China; 2019-39). The Ethical Review Board at Shanghai Jiao Tong University School of Medicine’s Ruijin Hospital approved of the study’s animal experimentation (China; RJ2023009).
: Not applicable.
: The authors declare no competing interests.